Last reviewed · How we verify

NCT05655962: STARS

A Structured Framework for Assessment of Rehabilitation and Sicklisting in Primary Care - a Multicenter Study

Status unknown NA Last updated 28 September 2023
What this trial tests

NA trial testing STARS in Public Health in 200 participants. Status unknown.

Timeline
1 September 2022
Primary endpoint
1 March 2025
1 March 2025

Quick facts

Lead sponsorRegion Östergötland
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment200
Start date1 September 2022
Primary completion1 March 2025
Estimated completion1 March 2025
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Region Östergötland

Who can join

Adults 18 to 65, any sex, with Public Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In a controlled pragmatic multicenter primary care study, centers working according to a newly constructed structured framework for assessment of rehabilitation and sicklisting (STARS) will be investigated. Nine intervention centers working according to STARS will be compared to matched control centers not working according to STARS. The design of this study includes qualitative as well as quantitative measures, with the aim to evaluate the effects of STARS at patient, staff, and organization levels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of STARS

Trials testing the same drug.

Other recruiting trials for Public Health

Currently open trials in the same condition.

Other Region Östergötland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05655962.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing